cemiplimab Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 1 (1)
Phase 2 (2)

Interventional (3)

Emory University (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
Vyriad, Inc. (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadmetastasis

I am/have/hadsquamous cell carcinoma of the skin

I am/have/hadnon-small cell lung cancer

I am/have/hadstage iv nsclc

I am/have/hadsquamous cell carcinoma

I am/have/hadlymphoma

I am/have/hadmonoclonal antibody therapy

I am/have/hadbiomarker analysis

I am/have/hadcarcinoma

I am/have/hadsystemic therapy

I am/have/hadendometrial adenocarcinoma

I am/have/hadhodgkin's disease

I am/have/hadantiviral therapy

I am/have/hadneuropathy

I am/have/hadcancer therapy

I am/have/hadmetastatic cutaneous squamous cell carcinoma

I am/have/hadadrenal insufficiency

I am/have/hadmajor surgery

I am/have/hadhypothyroidism

I am/have/hadoophorectomy

added new label for I am/have/had

I am looking for

I am looking formonoclonal antibodies

I am looking forheparin

I am looking formelanoma

I am looking forcemiplimab

I am looking forhepatitis b surface antigen

I am looking forprednisone

I am looking forsorafenib

I am looking forantiviral drugs

I am looking forimmune checkpoint inhibitor

I am looking forhepatitis b antigen

I am looking forfollicle stimulating hormone

I am looking foripilimumab

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

The purpose of this research study is to determine how people with weakened immune systems and unresectable (cannot be removed by surgery) locally recurrent and/or metastatic cutaneous squamous cell carcinoma (CSCC) respond to study treatment with Cemiplimab. Cemiplimab is approved for sale in United States by the U.S. Food and …

squamous cell carcinoma of the skin

metastasis

metastatic cutaneous squamous cell carcinoma

lymphoma

cemiplimab

0 views
16 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Dermatology
Recruiting

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

This is a Phase 2 study designed to determine the preliminary anti-tumor activity and confirm the safety of VV1 in combination with cemiplimab. The study will concurrently enroll patients with four distinct advanced malignancies in 5 separate tumor cohorts. The four cancers type are NSCLC and melanoma that are progressing …

metastasis

monoclonal antibodies

non-small cell lung cancer

melanoma

stage iv nsclc

0 views
16 Feb, 2024
9 locations

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Cemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer

Giving cemiplimab before surgery may improve risk of the cancer returning in patients with high risk cutaneous squamous cell cancer.

squamous cell carcinoma of the skin

metastasis

monoclonal antibodies

hormone replacement therapy

international normalized ratio

0 views
05 Aug, 2020